These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17442566)
1. A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome. van Swieten PF; Samuel E; Hernández RO; van den Nieuwendijk AM; Leeuwenburgh MA; van der Marel GA; Kessler BM; Overkleeft HS; Kisselev AF Bioorg Med Chem Lett; 2007 Jun; 17(12):3402-5. PubMed ID: 17442566 [TBL] [Abstract][Full Text] [Related]
2. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes. Loidl G; Groll M; Musiol HJ; Ditzel L; Huber R; Moroder L Chem Biol; 1999 Apr; 6(4):197-204. PubMed ID: 10099130 [TBL] [Abstract][Full Text] [Related]
3. C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors. Baldisserotto A; Marastoni M; Lazzari I; Trapella C; Gavioli R; Tomatis R Eur J Med Chem; 2008 Jul; 43(7):1403-11. PubMed ID: 17996987 [TBL] [Abstract][Full Text] [Related]
4. Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity. Marastoni M; Baldisserotto A; Cellini S; Gavioli R; Tomatis R J Med Chem; 2005 Jul; 48(15):5038-42. PubMed ID: 16033282 [TBL] [Abstract][Full Text] [Related]
5. Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit. Baldisserotto A; Marastoni M; Trapella C; Gavioli R; Ferretti V; Pretto L; Tomatis R Eur J Med Chem; 2007 May; 42(5):586-92. PubMed ID: 17291631 [TBL] [Abstract][Full Text] [Related]
6. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design. Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383 [TBL] [Abstract][Full Text] [Related]
7. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639 [TBL] [Abstract][Full Text] [Related]
8. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors. Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537 [TBL] [Abstract][Full Text] [Related]
9. Caspase inactivation of the proteasome. Cohen GM Cell Death Differ; 2005 Sep; 12(9):1218. PubMed ID: 16094401 [No Abstract] [Full Text] [Related]
10. Cell cycle-dependent caspase-like activity that cleaves p27(KIP1) is the beta(1) subunit of the 20S proteasome. Tambyrajah WS; Bowler LD; Medina-Palazon C; Sinclair AJ Arch Biochem Biophys; 2007 Oct; 466(2):186-93. PubMed ID: 17854759 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer. Dorsey BD; Iqbal M; Chatterjee S; Menta E; Bernardini R; Bernareggi A; Cassarà PG; D'Arasmo G; Ferretti E; De Munari S; Oliva A; Pezzoni G; Allievi C; Strepponi I; Ruggeri B; Ator MA; Williams M; Mallamo JP J Med Chem; 2008 Feb; 51(4):1068-72. PubMed ID: 18247547 [TBL] [Abstract][Full Text] [Related]
12. The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities. Kloss A; Henklein P; Siele D; Schmolke M; Apcher S; Kuehn L; Sheppard PW; Dahlmann B Eur J Pharm Biopharm; 2009 May; 72(1):219-25. PubMed ID: 19027853 [TBL] [Abstract][Full Text] [Related]
13. Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites. Britton M; Lucas MM; Downey SL; Screen M; Pletnev AA; Verdoes M; Tokhunts RA; Amir O; Goddard AL; Pelphrey PM; Wright DL; Overkleeft HS; Kisselev AF Chem Biol; 2009 Dec; 16(12):1278-89. PubMed ID: 20064438 [TBL] [Abstract][Full Text] [Related]
14. TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors. Sprangers R; Li X; Mao X; Rubinstein JL; Schimmer AD; Kay LE Biochemistry; 2008 Jul; 47(26):6727-34. PubMed ID: 18540636 [TBL] [Abstract][Full Text] [Related]
15. Development of proteasome inhibitors in oncology and autoimmune diseases. Bennett MK; Kirk CJ Curr Opin Drug Discov Devel; 2008 Sep; 11(5):616-25. PubMed ID: 18729013 [TBL] [Abstract][Full Text] [Related]
16. A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Verdoes M; Florea BI; Menendez-Benito V; Maynard CJ; Witte MD; van der Linden WA; van den Nieuwendijk AM; Hofmann T; Berkers CR; van Leeuwen FW; Groothuis TA; Leeuwenburgh MA; Ovaa H; Neefjes JJ; Filippov DV; van der Marel GA; Dantuma NP; Overkleeft HS Chem Biol; 2006 Nov; 13(11):1217-26. PubMed ID: 17114003 [TBL] [Abstract][Full Text] [Related]
17. Affinity labeling of the proteasome by a belactosin A derived inhibitor. Hasegawa M; Kinoshita K; Nishimura C; Matsumura U; Shionyu M; Ikeda S; Mizukami T Bioorg Med Chem Lett; 2008 Oct; 18(20):5668-71. PubMed ID: 18801655 [TBL] [Abstract][Full Text] [Related]
18. Arecoline tripeptide inhibitors of proteasome. Marastoni M; Baldisserotto A; Canella A; Gavioli R; Risi CD; Pollini GP; Tomatis R J Med Chem; 2004 Mar; 47(6):1587-90. PubMed ID: 14998343 [TBL] [Abstract][Full Text] [Related]
19. Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors. Baldisserotto A; Ferretti V; Destro F; Franceschini C; Marastoni M; Gavioli R; Tomatis R J Med Chem; 2010 Sep; 53(17):6511-5. PubMed ID: 20687609 [TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade. Yerlikaya A; Erin N Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]